FIELD: medicine, hepatology.
SUBSTANCE: the present innovation deals with treating infection induced by hepatitis B virus. For this purpose compounds and pharmaceutical compositions have been elaborated of specific antiviral activity, and, also, with the method to treat viral infection of hepatitis B. These elaborations deal with introduction of efficient quantity of didoxy-5-fluocytosine derivatives. The present innovation provides pronounced antiviral effect at decreased toxic manifestations of therapy conducted.
EFFECT: higher efficiency of application.
100 cl, 4 dwg, 4 ex, 2 tbl
Authors
Dates
2004-10-10—Published
1999-11-05—Filed